Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Deciphering a second component to the proteasomal degradation code
Translational Control by Osmotically Active Solutes
Indentification of Thyrothroph-Specific Transcription Fa
Genetics of A Behavioral Disorder;Tourette Syndrome (RG)
Tropospheric Chemistry of Isoprene, Monoterpenes and Their Atmospheric Reaction Products
Recently added grants:
Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease
FitMi Plus: Smart Functional Modules for Practicing Activities of Daily Living after Stroke
Modulation of Chronic Th2 inflammation by the CCR8 Receptor-Ligand Pathway
Vanderbilt HIV Clinical Trials Unit (CTU)
Alcohol Research Center - Treatment and Implications
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35153-9-0-1
Application #
7579653
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/ University of Wisconsin Madison
$1,614,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bailey, Howard /
$1,058,141
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/
Comments
Be the first to comment on this grant